Report cover image

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 341 Pages
SKU # DAABD18360463

Description

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market


The global Acute Respiratory Distress Syndrome (ARDS) treatment market is expected to reach USD 9,954,720.47 thousand by 2030, from USD 4,577,440.16 thousand in 2022, growing at the CAGR of 10.6% in the forecast period of 2023 to 2030.
Market Segmentation
Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type (Mechanical Ventilation, Corticosteroids, Antiviral Medication, Extracorporeal Membrane Oxygenation (ECMO), Tocilizumab, and Others), Cause ( Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, and Others), Route of Administration (Parenteral, Oral, and Others), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Turkey, Hungary, Netherlands, Switzerland, Austria Lithuania, Poland, Russia, Ireland, Norway, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Israel, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina, Peru, Rest of South America - Industry Trends and Forecast to 2030

Overview of Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Dynamics

Driver
• Increasing prevalence and incidence of acute lung injury in the market

Restraint

• High cost of device and treatment

Opportunity

• Strategic initiatives joined with new product launches by market players
Market Players

Some of the major market players operating in the global Acute Respiratory Distress Syndrome (ARDS) treatment market are listed below:

• Gilead Sciences, Inc.
• Terumo Medical Corporation
• Getinge
• LivaNova PLC
• Medtronic
• ResMed
• Fisher & Paykel Healthcare Limited.
• Drägerwerk AG & Co. KGaA
• NIPRO
• Fresenius SE & Co. KGaA
• Hamilton Medical
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• EUROSETS
• Armstrong Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Besmed Health Business Corp.

Table of Contents

341 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Acute Respiratory Distress Syndrome (Ards) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Insurance Reimbursement
4.3.1 Center For Medicare Services (Cms)–elso (Extracorporeal Life Support Organization)
4.3.2 Health Resources And Services Administration
4.3.3 Abbott Coding Guide For Ecmo
4.3.4 Central Government Health Scheme (Cghs)
4.3.5 Cern Health Insurance Scheme
4.3.6 American Society Of Clinical Oncology (Asco) – (Medicare & Medicaid)
4.3.7 American Hospital Association
4.4 Pipeline Analysis
4.5 Pricing Analysis
5 Market Overview
5.1 Drivers
5.1.1 Increasing Prevalence And Incidence Of Acute Lung Injury
5.1.2 Wide Range Of Risk Factors For Ards Treatment
5.1.3 Rising Rate Of Air Pollution And Unhealthy Lifestyle
5.1.4 Increasing Accident Rates And Trauma Causing Ards
5.2 Restraints
5.2.1 Complications Associated With The Treatment
5.2.2 High Cost Of Devices And Treatment
5.3 Opportunities
5.3.1 Rising Healthcare Expenditure To Improve Treatment Facilities
5.3.2 Strategic Initiatives Joined With New Product Launch By Market Players
5.3.3 Improving Awareness Regarding Ard Syndrome
5.4 Challenges
5.4.1 Stringent Rules & Regulations
5.4.2 Multiple Challenges Faced By Icu Staff
6 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type
6.1 Overview
6.2 Mechanical Ventilation
6.2.1 High-flow Nasal O2
6.2.2 Bi-level Positive Airway Pressure
6.2.3 Continuous Positive Airway Pressure
6.2.4 Prone Position Ventilation
6.2.5 Others
6.3 Corticosteroids
6.3.1 Methylprednisolone
6.3.2 Dexamethasone
6.3.3 Others
6.4 Antiviral Medication
6.4.1 Ribavirin
6.4.2 Oseltamivir
6.4.3 Others
6.5 Extracorporeal Membrane Oxygenation (Ecmo)
6.6 Tocilizumab
6.7 Others 89 
7 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause
7.1 Overview
7.2 Sepsis
7.3 Inhalation Of Harmful Substances
7.4 Severe Pneumonia
7.5 Others
8 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration
8.1 Overview
8.2 Parenteral
8.2.1 Intravenous
8.2.2 Intramuscular
8.3 Oral
8.4 Others
9 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User
9.1 Overview
9.2 Hospitals
9.3 Specialty Clinics
9.4 Home Healthcare
9.5 Others
10 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel
10.1 Overview
10.2 Direct Tender
10.3 Hospital Pharmacy
10.4 Retail Pharmacy
10.5 Online Pharmacy 113 
11 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Turkey
11.3.7 Netherlands
11.3.8 Switzerland
11.3.9 Belgium
11.3.10 Russia
11.3.11 Rest Of Europe
11.4 Asia-pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 South Korea
11.4.5 Australia
11.4.6 Singapore
11.4.7 Thailand
11.4.8 Malaysia
11.4.9 Indonesia
11.4.10 Philippines
11.4.11 Rest Of Asia-pacific
11.5 South America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest Of South America 266 
11.6 Middle East And Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 U.A.E
11.6.4 Israel
11.6.5 Egypt
11.6.6 Kuwait
11.6.7 Rest Of Middle East And Africa
12 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, Company Landscape
12.1 Company Share Analysis: Global
12.2 Company Share Analysis: North America
12.3 Company Share Analysis: Europe
12.4 Company Share Analysis: Asia-pacific
13 Swot Analysis
14 Global Acute Respiratory Distress Syndrome (Ards) Treatment, Cps
14.1 Gilead Sciences Inc.
14.1.1 Company Snapshot
14.1.2 Revenue Analysis
14.1.3 Company Share Analysis
14.1.4 Product Portfolio
14.1.5 Recent Development
14.2 Terumo Corporation
14.2.1 Company Snapshot
14.2.2 Revenue Analysis
14.2.3 Company Share Analysis
14.2.4 Product Portfolio
14.2.5 Recent Development
14.3 Getinge
14.3.1 Company Snapshot
14.3.2 Revenue Analysis
14.3.3 Company Share Analysis
14.3.4 Product Portfolio
14.3.5 Recent Development 314 
14.4 Livanova Plc
14.4.1 Company Snapshot
14.4.2 Revenue Analysis
14.4.3 Company Share Analysis
14.4.4 Product Portfolio
14.4.5 Recent Developments
14.5 Medtronic
14.5.1 Company Snapshot
14.5.2 Revenue Analysis
14.5.3 Company Share Analysis
14.5.4 Product Portfolio
14.5.5 Recent Developments
14.6 Armstrong Medical
14.6.1 Company Snapshot
14.6.2 Product Portfolio
14.6.3 Recent Development
14.7 Besmed Health Business Corp.
14.7.1 Company Snapshot
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.8 Drägerwerk Ag & Co. Kgaa
14.8.1 Company Snapshot
14.8.2 Revenue Analysis
14.8.3 Product Portfolio
14.8.4 Recent Developments
14.9 Eurosets
14.9.1 Company Snapshot
14.9.2 Product Portfolio
14.9.3 Recent Development
14.10 Fisher & Paykel Healthcare Limited
14.10.1 Company Snapshot
14.10.2 Revenue Analysis
14.10.3 Product Portfolio
14.10.4 Recent Developments
14.11 Fresenius Se & Co. Kgaa.
14.11.1 Company Snapshot
14.11.2 Revenue Analysis
14.11.3 Product Portfolio
14.11.4 Recent Development 328 
14.12 Hamilton Medical
14.12.1 Company Snapshot
14.12.2 Product Portfolio
14.12.3 Recent Development
14.13 Nice Neotech Medical Systems Pvt.Ltd.
14.13.1 Company Snapshot
14.13.2 Product Portfolio
14.13.3 Recent Development
14.14 Nipro
14.14.1 Company Snapshot
14.14.2 Revenue Analysis
14.14.3 Product Portfolio
14.14.4 Recent Development
14.15 Pfizer Inc.
14.15.1 Company Snapshot
14.15.2 Revenue Analysis
14.15.3 Product Portfolio
14.15.4 Recent Development
14.16 Resmed
14.16.1 Company Snapshot
14.16.2 Revenue Analysis
14.16.3 Product Portfolio
14.16.4 Recent Development
14.17 Weinmann Emergency Medical Technology Gmbh + Co. Kg
14.17.1 Company Snapshot
14.17.2 Product Portfolio
14.17.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables
Table 1 List Of Prices For Approved Drugs For Acute Respiratory Distress Syndrome (Ards) Treatment
Table 2 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 3 Global Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 4 Global Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 5 Global Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 6 Global Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 7 Global Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 8 Global Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 9 Global Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 10 Global Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 11 Global Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 12 Global Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 13 Global Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 14 Global Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 15 Global Extracorporeal Membrane Oxygenation (Ecmo) In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 16 Global Tocilizumab In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 17 Global Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 18 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 19 Global Sepsis In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 20 Global Inhalation Of Harmful Substances In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 21 Global Severe Pneumonia In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 22 Global Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 23 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 24 Global Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 25 Global Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 26 Global Oral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 27 Global Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 28 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 29 Global Hospitals In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 30 Global Specialty Clinics In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 31 Global Home Healthcare In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 32 Global Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 33 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 34 Global Direct Tender In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 35 Global Hospital Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 36 Global Retail Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 37 Global Online Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 38 Global Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Million)
Table 39 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 40 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 41 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 42 North America Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 43 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 44 North America Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 45 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 46 North America Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 47 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 48 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 49 North America Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 50 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 51 North America Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 52 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 53 U.S. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 54 U.S. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 55 U.S. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 56 U.S. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 57 U.S. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 58 U.S. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 59 U.S. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 60 U.S. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 61 U.S. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 62 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 63 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 64 U.S. Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 65 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 66 U.S. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 67 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 68 Canada Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 69 Canada Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 70 Canada Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 71 Canada Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 72 Canada Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 73 Canada Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 74 Canada Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 75 Canada Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 76 Canada Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 77 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 78 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 79 Canada Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 80 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 81 Canada Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 82 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 83 Mexico Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 84 Mexico Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 85 Mexico Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 86 Mexico Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 87 Mexico Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 88 Mexico Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 89 Mexico Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 90 Mexico Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 91 Mexico Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 92 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 93 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 94 Mexico Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 95 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 96 Mexico Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 97 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 98 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 99 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 100 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 101 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 102 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 103 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 104 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 105 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 106 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 107 Europe Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 108 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 109 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 110 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 111 Germany Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 112 Germany Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 113 Germany Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 114 Germany Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 115 Germany Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 116 Germany Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 117 Germany Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 118 Germany Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 119 Germany Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 120 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 121 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 122 Germany Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 123 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 124 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 125 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 126 France Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 127 France Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 128 France Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 129 France Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 130 France Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 131 France Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 132 France Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 133 France Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 134 France Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 135 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
Table 136 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 137 France Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 138 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 139 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 140 U.K. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 141 U.K. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 142 U.K. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 143 U.K. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 144 U.K. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 145 U.K. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 146 U.K. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
Table 147 U.K. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 148 U.K. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
Table 149 U.K. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us